COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00277017
Recruitment Status : Completed
First Posted : January 13, 2006
Last Update Posted : September 27, 2011
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2005
Actual Study Completion Date : August 2005